Nina Langeland

Position

Professor/consultant

Affiliation

Research

Research on clinical infectious diseases and outbreak investigations. Postinfectious syndromes. Several projects on the importance of antimicrobial resistance and ESBLs on morbidity and mortality in children in Tanzania. Placebo-controlled RCTs on cotrimoxazole prophylaxis in HIV infected patients with CD4 count over 350, and on hepatitis C treatment. Recently completed RCT on  probiotics to newborn babies. Clinical studies on COVID-19 including attack rate studies, vaccination and postinfectious complications. Ongoing placebo-controlled trial on antiviral treatment of COVID-19 and effect on long-term complications.

Experience in phase 1 studies, cohohort and case control studies, and randomized controlled trials. 

Publications

Academic article

Academic literature review

Study protocol

Conference lecture

Doctoral thesis (PhD)

Conference abstract

Letter to the editor

Master’s thesis

Research report

Media feature article

Conference poster

Journal corrigendum

See a complete overview of publications in NVA.